1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Failure of responsive regulation? : Pharmaceutical marketing, corporate impression management and off-label promotion of enzalutamide in Europe
(
- Contribution to journal › Article
- 2020
-
Mark
The importance of geographical distance to different types of R&D collaboration in the pharmaceutical industry
(
- Contribution to journal › Article
-
Mark
The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug Relenza
(
- Contribution to journal › Article
- 2019
-
Mark
Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK
(
- Contribution to journal › Article
- 2018
-
Mark
Drivers of pharmaceutical packaging innovation: a customer-supplier relationship case study
(
- Contribution to journal › Article
-
Mark
Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
(
- Contribution to journal › Article
- 2017
-
Mark
Exploring pharmaceutical packaging innovation management: a customer-supplier relationship case study
2017) 7th Global Innovation and Knowledge Academy(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2015
-
Mark
Divergence and convergence of commercial and scientific priorities in drug development: the case of Zelmid, the first SSRI antidepressant
(
- Contribution to journal › Article
-
Mark
Design process for innovation in pharmaceutical packaging: reviewing needs and modes of activity
(
- Contribution to conference › Other
- 2009
-
Mark
Design and testing of a small-scale sublimation apparatus
(
- Contribution to journal › Article